Colonic & Gastric Polypectomy: Endoscopic Polyp Removal Guide — Cost, Top Hospitals & Success Rates | MyMedicPlus

Polypectomy is an endoscopic procedure to remove abnormal tissue growths (polyps) from the lining of the gastrointestinal (GI) tract — most commonly the colon (colonoscopic polypectomy) or the stomach (gastric polypectomy performed during upper GI endoscopy). Polyps are localised, abnormal growths of the mucosal lining that project into the bowel or stomach lumen; while most are benign, a proportion harbour pre-cancerous or cancerous changes and require removal to prevent progression to invasive colorectal or gastric carcinoma.

The procedure is performed using a flexible endoscope — a thin, illuminated camera — that is inserted through the mouth (for gastric polypectomy) or the anus (for colonoscopic polypectomy). When a polyp is identified, the endoscopist uses purpose-built instruments passed through the endoscope's working channel to resect the polyp from its base and retrieve it for histopathological examination. The choice of resection technique depends on polyp morphology, size, location, and the endoscopist's assessment of depth of invasion.

Polypectomy is a cornerstone of cancer prevention programmes worldwide. Regular colonoscopy with polypectomy has been demonstrated in landmark randomised controlled trials (NordICC trial, CONFIRM trial) to significantly reduce colorectal cancer incidence and mortality. As an outpatient endoscopic procedure requiring no skin incisions, it carries a low risk profile and enables same-day discharge in the majority of cases, making it highly suitable for international medical travellers seeking cost-effective GI care.

Polypectomy addresses the following polyp types and associated conditions:

• Adenomatous polyps (adenomas) of the colon: The most clinically significant polyp type; tubular, tubulovillous, and villous adenomas have increasing malignant potential; high-grade dysplasia within an adenoma is a direct precursor to colorectal adenocarcinoma
• Hyperplastic and serrated polyps: Traditional hyperplastic polyps are largely benign, but sessile serrated lesions (SSLs) and traditional serrated adenomas (TSAs) carry pre-cancerous risk via the serrated pathway and should be removed
• Familial adenomatous polyposis (FAP): Hereditary condition causing hundreds to thousands of colonic adenomas; endoscopic surveillance and polypectomy is part of lifelong management alongside prophylactic colectomy consideration
• Lynch syndrome polyp surveillance: Accelerated adenoma-to-carcinoma sequence; intensive colonoscopic surveillance with polypectomy at shorter intervals
• Gastric fundic gland polyps: Common in patients on long-term proton pump inhibitor therapy; generally benign but require histological confirmation
• Gastric adenomatous polyps: Pre-cancerous lesions associated with chronic atrophic gastritis (often Helicobacter pylori-related); removal plus H. pylori eradication is recommended
• Hyperplastic gastric polyps: Usually benign; large polyps (>1–2 cm) warrant removal due to rare malignant potential and risk of obstruction at the pylorus
• Peutz-Jeghers polyps (hamartomas): Occur throughout the GI tract in Peutz-Jeghers syndrome; large polyps may cause obstruction or intussusception and require endoscopic or surgical removal

Polypectomy is recommended for any patient with endoscopically confirmed polyps in the colon or stomach that meet criteria for removal. Specific candidacy considerations include:

• Polyp detected on colonoscopy or gastroscopy: Any polyp identified during diagnostic endoscopy will generally be removed at the same session if technically feasible and the patient consented to resection
• Polyps on CT colonography (virtual colonoscopy): Patients with polyps ≥6 mm identified on CT colonography are referred for diagnostic colonoscopy and polypectomy
• Positive faecal occult blood test or faecal immunochemical test (FIT): A positive FIT result triggers diagnostic colonoscopy; polyps found are removed at the same sitting
• Symptomatic polyps: Rectal bleeding, change in bowel habits, iron deficiency anaemia, or obstructive symptoms from large polyps
• Hereditary polyposis syndromes: Patients with FAP, MUTYH-associated polyposis, Lynch syndrome, or Peutz-Jeghers syndrome require regular surveillance colonoscopies with polypectomy
• Fitness for procedure: Most patients tolerate endoscopic polypectomy under conscious sedation; colonoscopy bowel preparation is essential and requires a clear liquid diet the day before and ingestion of an osmotic laxative
• Anticoagulation management: Patients on warfarin, direct oral anticoagulants (DOACs), or antiplatelet agents require planned drug interruption before polypectomy of medium or large polyps to reduce bleeding risk; low-dose aspirin is generally continued

The technique chosen depends on polyp size, morphology (pedunculated vs. sessile, Paris classification), and suspected depth of invasion (assessed by dye-spray or narrow-band imaging):

• Cold snare polypectomy (CSP): Current gold-standard for small polyps (≤9 mm). A wire snare is placed around the polyp and closed to mechanically sever it without electrocautery; eliminates electrocautery-related delayed bleeding and perforation risk while achieving excellent histological assessment. Preferred for diminutive (≤5 mm) and small sessile polyps.
• Hot snare polypectomy: Electrocautery current applied through the snare loop as it closes, coagulating tissue as the polyp is severed. Traditionally used for medium polyps (10–19 mm) but increasingly replaced by cold snare techniques; risk of delayed post-polypectomy bleeding remains approximately 1–2%.
• Endoscopic mucosal resection (EMR): For flat or sessile polyps 20 mm or larger. A saline-based solution (often with dilute adrenaline and methylene blue) is injected under the polyp to lift it away from the deeper muscular layer, then a snare is used to resect the lifted lesion in one piece (en bloc) or in sections (piecemeal EMR). Piecemeal EMR carries a recurrence rate of 10–15% at the resection scar, requiring surveillance endoscopy at 3–6 months.
• Endoscopic submucosal dissection (ESD): Advanced technique using electrosurgical knives to dissect directly within the submucosal layer, achieving en-bloc resection of large lesions regardless of size. Provides superior histological staging and lower recurrence rates than piecemeal EMR but requires greater endoscopic expertise and carries higher perforation risk (3–5%). Widely practiced in Japan, South Korea, and increasingly in specialised Western centres.
• Cold forceps biopsy: Used only for diminutive polyps (≤3 mm) where snare placement is impractical; piecemeal forceps removal is less reliable and not recommended for polyps >4 mm.
• Laparoscopic-assisted polypectomy: For very large or difficult-to-access polyps where purely endoscopic removal is unsafe (risk of perforation), a combined approach using laparoscopic trocar placement to manually support the colon wall while the endoscopist resects from within is used.

All removed tissue is retrieved and submitted to histopathology. The resection margins and degree of dysplasia determine subsequent surveillance intervals per national guidelines (ESGE, ACG, BSG).

Polypectomy offers substantial clinical and preventive benefits:

• Cancer prevention: Removal of adenomatous polyps reduces colorectal cancer incidence by approximately 70–90% in population-based colonoscopy programmes; the National Polyp Study demonstrated 76–90% reduction in CRC incidence following complete adenoma removal
• Same-session removal: Most polyps detected during diagnostic endoscopy are removed at the same procedure, avoiding a return visit and additional bowel preparation
• Minimally invasive: No skin incisions, no general anaesthesia in most cases, rapid recovery — most patients return to normal diet and activities within 24–48 hours
• High technical success rates: Experienced endoscopists achieve complete resection (R0) in over 90% of polyps ≤20 mm; ESD achieves en-bloc resection in over 95% of lesions
• Accurate histological diagnosis: Resected polyps provide complete tissue for staging; pathology results guide surveillance intervals and identify the rare T1 cancer in a polyp (carcinoma in polyp) that may be managed endoscopically without surgery
• Reduced anxiety: Patients with hereditary polyposis syndromes gain reassurance from regular surveillance with proactive removal of developing lesions
• Cost-effectiveness: Population colonoscopy with polypectomy is highly cost-effective compared to colorectal cancer treatment and is endorsed in international cancer prevention guidelines

Polypectomy is a safe procedure but carries the following recognised risks:

• Post-polypectomy bleeding: The most common complication; occurs in approximately 0.5–2% of polypectomies, more commonly after large polyp resection and hot snare technique. Presents as rectal bleeding up to 14 days post-procedure. The majority (over 90%) of post-polypectomy bleeds are managed endoscopically (clip placement, argon plasma coagulation, injection therapy) without surgery.
• Perforation: Transmural injury creating a hole in the bowel wall; occurs in approximately 0.1–0.5% of colonoscopic polypectomies and up to 3–5% of ESD procedures. Small perforations are increasingly managed with endoscopic clip closure; larger perforations or delayed presentations may require emergency surgery.
• Post-polypectomy syndrome: A localised electrocoagulation injury causing delayed abdominal pain, fever, and raised inflammatory markers without frank perforation; typically managed conservatively with antibiotics and bowel rest; occurs in about 1% of cases.
• Incomplete resection: Residual adenoma at the polypectomy scar increases cancer risk; piecemeal EMR of large lesions has a 10–20% local recurrence rate requiring repeat endoscopy at 3–6 months.
• Bowel preparation complications: Dehydration and electrolyte disturbance from osmotic laxative preparation; of particular concern in elderly patients and those with renal impairment.
• Sedation risks: Cardiorespiratory events from intravenous sedation are rare (<0.1%) but increase with patient age, obesity, and cardiopulmonary comorbidity.

Recovery from colonic or gastric polypectomy is typically swift, with post-procedure care and surveillance requirements determined by histopathology results:

• Immediate post-procedure (Hours 1–4): Recovery room observation until sedation clears; mild abdominal bloating and flatulence from air insufflation is normal and resolves within hours; clear fluids initially, then light diet
• Days 1–3: Avoid strenuous exercise, alcohol, and NSAIDs; a low-residue diet may be advised for 24–48 hours after large resections; minor spotting of blood on first bowel motion after rectal polypectomy is normal
• Warning signs requiring urgent medical attention: Heavy rectal bleeding, persistent or worsening abdominal pain, fever, or rigors in the 2 weeks after the procedure should be reported immediately
• Colonoscopy surveillance intervals (per ESGE 2020 guidelines):
  • No polyps: repeat colonoscopy at 10 years (average risk) or per screening programme
  • 1–4 small tubular adenomas (low-risk): colonoscopy at 3–5 years
  • High-risk adenomas (≥5 adenomas, any adenoma ≥10 mm, villous histology, high-grade dysplasia): colonoscopy at 1–3 years
  • Piecemeal EMR scar: follow-up at 3–6 months then per histology
• Gastric polyp follow-up: Depends on polyp type and presence of H. pylori; adenomatous gastric polyps warrant repeat gastroscopy at 12 months
• H. pylori treatment: If detected, eradication with a standard triple or quadruple therapy regimen (proton pump inhibitor + antibiotics) is recommended to reduce recurrence of gastric polyps and gastric cancer risk

The cost of colonic or gastric polypectomy varies significantly by country, setting, and complexity of the procedure:

• United States: $2,000–$9,000 for colonoscopy with polypectomy (outpatient facility); complex EMR or ESD can reach $12,000–$20,000 including facility, physician, anaesthesiology, and pathology fees; largely covered by insurance for screening-indicated procedures
• United Kingdom: NHS provision is free at point of care; private gastroenterology: £1,200–£3,500 for colonoscopy with polypectomy; complex ESD £4,000–£8,000
• India: $300–$800 for diagnostic colonoscopy with polypectomy at accredited hospitals; ESD $1,000–$3,000 — representing savings of 80–90% versus US pricing
• Thailand: $800–$2,500 at Bangkok hospitals; internationally trained endoscopists; modern endoscopy suites
• Turkey & Eastern Europe: $500–$1,800 for colonoscopy polypectomy; ESD available at major academic centres
• Cost influencing factors:
  • Number of polyps detected and removed (single polypectomy vs. multiple)
  • Technique used (cold snare vs. EMR vs. ESD)
  • Polyp size and complexity
  • Anaesthesia type (conscious sedation vs. general anaesthesia)
  • Histopathology examination fees (charged per specimen)
  • Inpatient vs. day-procedure setting

In certain clinical scenarios, alternatives to standard endoscopic polypectomy are considered:

• Active surveillance (watchful waiting): For diminutive hyperplastic-appearing rectal polyps (≤5 mm) in low-risk locations, some guidelines support a 'resect and discard' or even 'diagnose and leave' approach with narrow-band imaging, avoiding resection of lesions with negligible cancer risk
• Surgical colonic resection: Required when endoscopic removal is not technically feasible (very large non-lifting lesions, lesions in difficult anatomical positions), when histopathology reveals T1 cancer with adverse features (deep submucosal invasion, lymphovascular invasion, poor differentiation), or in FAP patients requiring prophylactic colectomy
• Argon plasma coagulation (APC): Used as an adjunct after piecemeal EMR to ablate small residual adenoma fragments at the resection edge; not a primary resection modality
• Laser ablation: Nd:YAG laser has been used for rectal adenomas in patients unfit for surgery; largely superseded by EMR/ESD in centres with endoscopic expertise
• Transanal endoscopic microsurgery (TEM) / TAMIS: For large rectal polyps not amenable to endoscopic resection; provides full-thickness excision under magnified vision through a purpose-built transanal platform; preserves the rectum without laparotomy
• Dietary and chemoprevention: Aspirin and NSAIDs have demonstrated polyp recurrence reduction in high-risk individuals (FAP, Lynch) but are not replacements for endoscopic surveillance and polypectomy